A New Jersey cardiologist specializing in electrophysiology was sentenced July 31 to 20 months in prison for billing the Veterans Affairs (VA) program hundreds of thousands of dollars for services he never performed.

A calcium-channel blocker delivered as a nasal spray rapidly restored individuals with paroxysmal supraventricular tachycardia (SVT) to normal sinus rhythm in a phase 2 study, raising the possibility that the drug could be self-administered in a real-world setting and prevent trips to the emergency department.

Epinephrine doses administered by paramedics significantly improved the odds of 30-day survival for patients following out-of-hospital cardiac arrest (OHCA), according to a randomized, placebo-controlled trial published in the New England Journal of Medicine. The survivors who received epinephrine, however, had worse neurological outcomes.

Asthma and uncontrolled asthma are associated with a 38 percent increased risk of developing atrial fibrillation (AFib), according to new research published in JAMA Cardiology.

Non-vitamin K antagonist oral anticoagulants may be even more effective for treating women with atrial fibrillation (AFib) than men, suggests a real-world study from Hong Kong published in the Journal of the American College of Cardiology.

The more a person smokes, the greater the risk of developing a heart rhythm disorder, according to a new study published July 11 in the European Journal of Preventive Cardiology.

Blacks who survive in-hospital cardiac arrest (IHCA) are 28 percent less likely to live to one year after discharge and 33 percent less likely to survive five years when compared to white counterparts, suggesting a disparity in follow-up care.

Nonsteroidal anti-inflammatory drugs (NSAIDs) can be dangerous for patients with atrial fibrillation (AFib) when taken on top of oral anticoagulants, suggests a post hoc analysis of the RE-LY trial published in the Journal of the American College of Cardiology.